IP Verse

Hampton Knowles competitive analysis

Explore the latest publications and patents granted to Hampton Knowles, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Hampton Knowles against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3487881	Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 Antagonists	NOVARTIS	May 21, 2025
EP4133426	Machine Learning Driven Chemical Compound Replacement Technology	NOTCO DELAWARE	May 20, 2025
EP4209499	Charged Depth Filtration Of Antigen-Binding Proteins	AMGEN	May 7, 2025
EP3458466	Diagnosis Of Inflammatory Bowel Disease Based On Genes	CEDARS SINAI MEDICAL CENTER	May 6, 2025
EP3506931	Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Apr 30, 2025
EP4172301	Low Diacetyl Yeast	CARLSBERG	Apr 24, 2025
EP3889181	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jan 24, 2025
EP4181933	Antiviral Pharmaceutical Composition Comprising At Least One Sulphate Polysaccharide	MARINOMED BIOTECH	Jan 17, 2025
EP3191120	Use Of Il-17 Antagonists To Inhibit The Progression Of Structural Damage In Psoriatic Arthritis Patients	NOVARTIS	Jan 10, 2025
EP3738508	Flexible High-Density Mapping Catheter Tips And Flexible Ablation Catheter Tips With Onboard High-Density Mapping Electrodes	ST JUDE MEDICAL	Nov 28, 2024

Discover the latest PTAB cases involving Hampton Knowles, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Hampton Knowles with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
HAMPTON KNOWLES	24	-	-	-	Highly Aggressive
NOVARTIS	6	406	-	21	Defensive
REGENERON PHARMACEUTICALS	38	93	9	30	Balanced
SANOFI BIOTECHNOLOGY	-	50	-	-	Non-Active